Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | ARO-HIF2 |
Synonyms | |
Therapy Description |
ARO-HIF2 consists of RNA interfering molecules that selectively target HIF2A (EPAS1) transcript and block HIF2A expression, thereby potentially resulting in the inhibition of tumor growth (Cancer Res 2019;79(13 Suppl):Abstract nr 4775). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
ARO-HIF2 | AROHIF2|TRiM ARO HIF2|HIF2a RNAi ARO-HIF2 | ARO-HIF2 consists of RNA interfering molecules that selectively target HIF2A (EPAS1) transcript and block HIF2A expression, thereby potentially resulting in the inhibition of tumor growth (Cancer Res 2019;79(13 Suppl):Abstract nr 4775). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT04169711 | Phase I | ARO-HIF2 | Study of ARO-HIF2 in Patients With Advanced Clear Cell Renal Cell Carcinoma | Completed | USA | 0 |